disease that is highly resistant to traditional therapies. 2 Despite the advances in diagnosis and therapy, such as surgery, chemotherapy and radiation, there are high rates of recurrence and metastasis among patients with BC. 3 Besides, continuous treatment with radiotherapy and chemotherapy leads to less effective destruction of cancer cells due to the acquired resistance. 4 Therefore, the molecular mechanisms underlying BC tumorigenesis need to be further investigated.
Long noncoding RNAs (lncRNAs) are defined as transcripts that have more than 200 nucleotides and lack protein-coding capacity. 2 LncRNAs have been reported to involve in tumor progression and metastasis through regulating different levels biological processes, such as mRNA alternative splicing, protein activities, changes of protein localization, etc. 2, 5 A growing number of literatures reported that lncRNAs are tightly linked to human cancer and involved in the control of availability for specific miRNAs. 6 In BC, a number of differentially expressed lncRNAs and their correlation with tumorigenic functions were reported. [7] [8] [9] For example, lncRNA FOXO1 was notably down-regulated in BC and inhibited the growth of BC by increasing FOXO1 transcription. 7 While, linc-ITGB1 was greatly upregulated in BC which promoted cell metastasis. genes to accomplish the function of different subtypes of lung cancer. 10 Miano et al discovered that overexpression of DSCAM-AS1 promoted the growth of a luminal breast cancer cell line. 12 Of note, Niknafs et al showed that DSCAM-AS1 could interact with hnRNPL to mediate tumor progression. 11 However, the whole story of how DSCAM-AS1-mediated luminal BC growth and progression largely remains unknown. Therefore, a further understanding of DSCAM-AS1-regulated targets and networks is needed.
MicroRNAs (miRNAs) are small noncoding RNA molecules of 19-25 nucleotides and can act as post-transcriptional regulators by binding to complementary sequences of target mRNAs. 13 MiRNAs were involved in cellular processes including cell proliferation, differentiation, and apoptosis. 1, [13] [14] [15] A host of evidences have revealed that dysregulation of miRNAs is associated with BC tumorigenesis and metastasis. MiR-204-5p is a type of miRNA, and previously studies have reported that miR-204-5p was downregulated in several human cancers and might act as a tumor inhibitor. 16 For example, low levels of miR-204-5p expression were confirmed in hepatocellular carcinoma, 16 oral squamous cell carcinoma, 17 gastric cancer. 18 papillary thyroid carcinoma, 19 and glioma. 20 And miR-204-5p has been confirmed to associate with BC cells, and overexpression of miR-204-5p might suppress cell migration and invasion of BC. 13 
| Microarray analysis
The breast tumor tissue data were collected from TCGA database (https://cancergenome.nih.gov). The "DESeq2" R-package was utilized to normalize, identify and visualize differentially expressed miRNAs and lncRNAs (log 2 |Fold Change| > 1 and P.adjust < 0.05). The "pheatmap" R- 
| Cell transfection
Overexpression of DSCAM-AS1 (isoform 2), the predominant U6 and GADPH were used as internal references. The 2 −ΔΔCt method was employed to quantify relative mRNA expression values. The specific primers used are presented in Table 2 .
| Western blot
Protein samples were lysed in RIPA buffer (Beyotime, Shanghai, China) with a cocktail of protease inhibitor (Roche, Basel, Switzerland). After 
| Flow cytometry

| Transwell assay
Cells were suspended in serum-free medium and placed into the upper chamber with coated Matrigel of a 24-well chamber (Sigma-Aldrich, St.
Louis, MO). Six-hundred-microliter media containing 10% FBS were added to the lower chamber overnight. Migrated cells were fixed with 4% paraformaldehyde and stained with crystal violet. Cells were rinsed and counted from random fields (×100 magnification). Each experiment was conducted triplicate. 
| Luciferase reporter assay
| Statistical analysis
All experiments were repeated at least three times. All statistical analyses were performed using GraphPad Prism 6.0 software Tables S1 and S2. Consistent with previous reports, our data supported that DSCAM-AS1 was highly expressed in luminal breast cancer tissues in comparison to adjacent tissues. We also found others researches 13, 29 have indicated that miR-204-5p is a breast tumor suppressor gene, which is also in line with our analysis. Thus, we were eager to further validate our bioinformatics analysis, we employed qRT-PCR to detect DSCAM-AS1 levels in BC tissue and adjacent tissue samples of forty hospital patients. The results indicated that in comparison with 
| DSCAM-AS1 target on miR-204-5p
Then, we were wondering the target candidates of DSCAM-AS1 and Figures 1C and 1D ). In conclusion, DSCAM-AS1 could regulate on 3′UTR of miR-204-5p.
| DSCAM-AS1 promoted BC cells proliferation and metastasis and impeded cell apoptosis by targeting miR-204-5p
The experiments were performed in four groups: NC group, miR-204-5p group, DSCAM-AS1 group, and miR-204-5p + DSCAM-AS1 group.
CCK-8 results showed that DSCAM-AS1 promoted the proliferation of BC cells, which was inhibited by miR-204-5p ( Figure 3A , P < 0.01).
Transwell assay results demonstrated that miR-204-5p had opposite effect on cell migration, while DSCAM-AS1 enhanced BC cells migration, and co-transfection of DSCAM-AS1 and miR-204-5p had Taken together, these panels demonstrated that DSCAM-AS1 has an inhibitory effect on miR-204-5p to promote BC cells proliferation and metastasis.
FIGURE 3
Effect of DSCAM-AS1 and miR-204-5p on BC cells activities. A, Cell vitality of HCC1937 cells transfected with DSCAM-AS1 was higher than that of cells in NC group, while that in miR-204-5p group was lower than that in NC group detected by CCK-8 assay. B-D, Transwell assays revealed that compared with NC group, more migrating or more invasive cells were found in DSCAM-AS1 group while less metastasis cancer cells were observed in miR-204-5p group. E, Flow cytometry showed that apoptosis rate in DSCAM-AS1 group was lower than that in NC group, while that in miR-204-5p group was much higher than that in NC group. **P < 0.01, compared with NC group. [Color figure can be viewed at wileyonlinelibrary.com]
| MiR-204-5p could act on RRM2
We hypothesized that RRM2 was a downstream of miR-204-5p and the target sites between them were predicted by using TargetScan and Miranda database. We mutated Region 1949-1956 of RRM2 as mentioned in the left panel Figure 4A . As verified by dual luciferase reporter assay, we confirmed that RRM2 is a target of miR-204-5p
(right panel, Figure 4A , P < 0.01). Meanwhile, we used qRT-PCR and western blot to separately detect the mRNA and protein expression of to cancer cell motility, adhesion, and invasion. 12 Xu et al revealed that the knockdown of DSCAM-AS1 inhibited BC cell proliferation and cycle progression as well as increased cell apoptosis in vitro.
2 FIGURE 4 MiR-204-5p could directly target on RRM2. A, The targeted site of miR-204-5p and RRM2 and experimental validation of it by dual luciferase reporter assays. **P < 0.01, compared with NC group. B, qRT-PCR revealed that RRM2 expression was up-regulated in tumor tissues. *P < 0.05, compared with adjacent tissues. C, Western blot showed that RRM2 protein expression in tumor tissues was higher than that in adjacent tissues. D, qRT-PCR revealed that RRM2 expression in miR-204-5p group was significantly lower than that in NC group. **P < 0.01, compared with NC group. E, Western blot showed that RRM2 protein expression decreased in HCC1937 cells when co-transfected with miR-204-5p. F, qRT-PCR revealed that RRM2 expression in sh-DSCAM-AS1 group was significantly lower than that in NC group. **P < 0. showed that compared with NC group, more migrating or more invasive cells were found in RRM2 group while less metastasis cells were observed in miR-204-5p group. E, Flow cytometry indicated that apoptosis rate in RRM2 group was lower than that in NC group, while apoptosis rate in miR-204-5p group was higher than that in NC group. **P < 0.01, compared with NC group. [Color figure can be viewed at wileyonlinelibrary.com]
FIGURE 6
Overexpression of DSCAM-AS1 promoted tumor growth. A, qRT-PCR indicated that DSCAM-AS1expression of HCC1937 cells transfected with DSCAM-AS1 was significantly higher than that cells transfected with sh-DSCAM-AS1. B, Tumor volume of DSCAM-AS1 group was larger than that of NC group. C, Tumor weight was much larger in DSCAM-AS1 group compared with NC group at day 30. D, Tumor diagram at day 30. E, qRT-PCR revealed that miR-204-5p expression in DSCAM-AS1 group was significantly lower than that in NC group. F, qRT-PCR showed that RRM2 expression was significantly higher in DSCAM-AS1 group compared with NC group. G, Western blot revealed that RRM2 protein expression in DSCAM-AS1 group was significantly higher than that in NC group. **P < 0.01, compared with NC group. [Color figure can be viewed at wileyonlinelibrary.com] pathology. The results indicated that miR-204-5p inhibited BC cells reproduction and enhanced cell apoptosis, the expression of which was inhibited by DSCAM-AS1.
RRM2, as a key gene in pyrimidine metabolism, was correlated with varied human tumors. 27 Previous literatures have reported that RRM2 had a high expression in cancer and was involved in tumor aggressiveness, poor prognosis, and chemoresistance. 32 For instance, Sturtz et al demonstrated that RRM2 expressed at higher levels in tumor tissues, associated with up-regulation of cellular propagation and invasiveness. 33 Shah et al revealed that RRM2 was overexpressed in tamoxifen-resistant BC cells, and enhanced the proliferation and metastasis of MCF-7 BC cells. 32 Consistently, we found that RRM2 was up-regulated in BC. Meanwhile, a series of experimental results indicated that the effects of RRM2 on BC cell activities were reversely changed by miR-204-5p. We clearly investigated the molecular mechanism underlying DSCAM-AS1, miR-204-5p, and RRM2 and revealed their relationship in BC for the first time.
However, some shortages of our study should be considered in our following researches. For instance, in vitro experiments of DSCAM-AS1 and RRM2 should be conducted to comprehensively understand the molecular network of DSCAM-AS1, miR-204-5p, and RRM2 in BC.
In conclusion, we validated that DSCAM-AS1 was elevated in BC cells as well as promoted the proliferation and metastasis of BC cells and suppressed cell apoptosis by inhibiting miR-204-5p and increasing RRM2
expression. Therefore, this study suggests that inhibition of DSCAM-AS1 may be a promising therapeutic strategy for treatment of BC.
